Arrowgrass Capital Partners (US)’s Mead Johnson Nutrition Company MJN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-458
Closed -$41K 662
2017
Q1
$41K Sell
458
-902
-66% -$74.2K ﹤0.01% 568
2016
Q4
$96K Buy
1,360
+347
+34% +$25.9K ﹤0.01% 521
2016
Q3
$80K Buy
+1,013
New +$86.4K ﹤0.01% 440
2015
Q1
Sell
-59,000
Closed -$5.93M 569
2014
Q4
$5.93M Buy
+59,000
New +$5.88M 0.11% 124
2013
Q4
Sell
-100,000
Closed -$7.43M 222
2013
Q3
$7.43M Buy
+100,000
New +$7.5M 0.28% 75

Other funds holding MJN

Arrowgrass Capital Partners (US)'s MJN Position: Q2 2017 in Review

Arrowgrass Capital Partners (US) sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 458 shares — an estimated $41K sold.

Arrowgrass Capital Partners (US) first reported a position in MJN in Q3 2013 and held it in 5 quarters. The position peaked at $7.43M in Q3 2013. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • Arrowgrass Capital Partners (US) reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • Arrowgrass Capital Partners (US) sold 458 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $41K.
  • Arrowgrass Capital Partners (US) first reported a position in Mead Johnson Nutrition Company in Q3 2013 and held it in 5 quarters.
  • Arrowgrass Capital Partners (US)'s Mead Johnson Nutrition Company position peaked at $7.43M in Q3 2013.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Arrowgrass Capital Partners (US)'s 13F filing for Q2 2017, filed 14 Aug 2017.